TABUTEAU HERRIOT (Chief Executive Officer) sold 87.3% of their position (49.67K shares) of AXSOME THERAPEUTICS, INC. on the open market
Open‑market sale worth $11.93M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0001193125-26-292985
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
-49.67K
Net shares
Net seller
$11.93M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
49.67K acquired · 99.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+49.67K
Price / share
$4.95
Trade value
$245.85K
% of position
687.0%
7/1/2026
7.23K→56.90K
Common Stock
Direct
Shares
−49.67K
Price / share
$240.25
Trade value
$11.93M
% of position
87.3%
7/1/2026
56.90K→7.23K
Total
Net shares
+0.00
Net value
-$11.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +49.67K | $4.95 | $245.85K | 687.0% | 7.23K | 56.90K |
| Common Stock Direct | 7/1/2026 | S · Sale | −49.67K | $240.25 | $11.93M | 87.3% | 56.90K | 7.23K |
| Total | +0.00 | -$11.69M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
49.67K shares
Shares
−49.67K
Strike price
240.25
Held after
49.66K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock49.67K shares | 7/1/2026 | M · Option Exercise | −49.67K | 240.25 | — | 49.66K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned7.34M
Total
7.34M indirect7.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.34M | Indirect |
| Total | 7.34M | 7.34M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported